http://schemas.microsoft.com/office/word/2003/wordml2450


                                        3
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

      Date of Report: (Date of earliest event reported) August 10, 2016


                           UNITED CANNABIS CORPORATION
                   -------------------------------------------
               (Exact name of registrant as specified in charter)


                                    Colorado
                ------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)


                              1600 Broadway, Suite 1600
      000-54582                    Denver, CO 80202               46-5221947
-----------------------   -----------------------------------  -----------------
   (Commission File        (Address of Principal Executive       (IRS Employer
       Number)                         Offices                  Identification
                                    and Zip Code)                   Number)


                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)


                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
     CFR 240.14a-12(b))

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

ITEM 1.01.  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

     See Item 2.03 of this report.

ITEM 2.03. CREATION OF DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN
           OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

JSJ Investments

     On August 10, 2016 the Company borrowed $125,000 from JSJ Investments, Inc.
The loan is evidenced by a promissory  note which bears interest at 12% per year
and is due and payable on May 10, 2017.

     The Company  received  $109,500 of net loan proceeds after deduction of the
original issue discount ($6,250) and payment of legal and due diligence fees.

     The  Company  may pay the Note at any time  prior to the date  which is 180
days  after the date of the Note  (the  "Prepayment  Date").  Until the 60th day
after the date of the Note, the Company may pay the principal of the Note,  plus
a premium of 25%, in  addition to  outstanding  interest,  without the  Holder's
consent.  From the 61st day after the date of the Note to the  Prepayment  Date,
the  Company  may pay the  principal  of the  Note,  plus a premium  of 30%,  in
addition to  outstanding  interest,  without  the  Holder's  consent.  After the
Prepayment  Date the Note may only be paid with the  Holder's  consent  and,  if
paid, will have a premium of 30% in addition to the then  outstanding  principal
amount of the Note plus accrued  interest.  At any time on or after the Maturity
Date,  the Company may repay the then  outstanding  principal of the Note,  plus
accrued interest, if any, to the Holder.

     At the option of the Holder,  the Note may be converted  into shares of the
Company's  common  stock.  The number of shares to be issued at each  conversion
will be  determined  by dividing the amount to be  converted  by the  Conversion
Price.  The Conversion  Price is $0.20 until the 180th day after the date of the
Note. After the 180th day of the Note, the Conversion Price is 55% of the lowest
trading price of the Company's  common stock during the 10 trading days prior to
the date of the conversion.

Item 3.02.  Unregistered Sales of Equity Securities.

     In connection with the issuance of the note referenced in Item 2.03 of this
report the Company relied upon the exemption  provided by Section 4(a)(2) of the
Securities Act of 1933. The holder of the note was a sophisticated  investor and
was provided full information  regarding the Company's  business and operations.
There was no general  solicitation  in connection with the issuance of the note.
No commission was paid to any person in connection with issuance of the note.

                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                      UNITED CANNABIS CORPORATION


Dated:  August 18, 2016              By:  /s/ Chad Ruby
                                          ------------------------------------
                                          Chad Ruby
                                          Chief Operating Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kjsjnote8-16.txt", "description": "FORM 8-K ITEM 1.01", "secsgml_size_bytes": 5564}]
{"company-data": {"conformed-name": "United Cannabis Corp", "cik": "0001436161", "assigned-sic": "2834", "irs-number": "261391338", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54582", "film-number": "161841720"}, "business-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(407) 432-2547"}, "mail-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "MySkin, Inc.", "date-changed": "20080528"}}
http://schemas.microsoft.com/office/word/2003/wordml2450

                                        3
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

      Date of Report: (Date of earliest event reported) August 10, 2016

                           UNITED CANNABIS CORPORATION
                   -------------------------------------------
               (Exact name of registrant as specified in charter)

                                    Colorado
                ------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)

                              1600 Broadway, Suite 1600
      000-54582                    Denver, CO 80202               46-5221947
-----------------------   -----------------------------------  -----------------
   (Commission File        (Address of Principal Executive       (IRS Employer
       Number)                         Offices                  Identification
                                    and Zip Code)                   Number)

                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
     CFR 240.14a-12(b))

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01.  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

     See Item 2.03 of this report.

ITEM 2.03. CREATION OF DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN
           OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

JSJ Investments

     On August 10, 2016 the Company borrowed $125,000 from JSJ Investments, Inc.
The loan is evidenced by a promissory  note which bears interest at 12% per year
and is due and payable on May 10, 2017.

     The Company  received  $109,500 of net loan proceeds after deduction of the
original issue discount ($6,250) and payment of legal and due diligence fees.

     The  Company  may pay the Note at any time  prior to the date  which is 180
days  after the date of the Note  (the  "Prepayment  Date").  Until the 60th day
after the date of the Note, the Company may pay the principal of the Note,  plus
a premium of 25%, in  addition to  outstanding  interest,  without the  Holder's
consent.  From the 61st day after the date of the Note to the  Prepayment  Date,
the  Company  may pay the  principal  of the  Note,  plus a premium  of 30%,  in
addition to  outstanding  interest,  without  the  Holder's  consent.  After the
Prepayment  Date the Note may only be paid with the  Holder's  consent  and,  if
paid, will have a premium of 30% in addition to the then  outstanding  principal
amount of the Note plus accrued  interest.  At any time on or after the Maturity
Date,  the Company may repay the then  outstanding  principal of the Note,  plus
accrued interest, if any, to the Holder.

     At the option of the Holder,  the Note may be converted  into shares of the
Company's  common  stock.  The number of shares to be issued at each  conversion
will be  determined  by dividing the amount to be  converted  by the  Conversion
Price.  The Conversion  Price is $0.20 until the 180th day after the date of the
Note. After the 180th day of the Note, the Conversion Price is 55% of the lowest
trading price of the Company's  common stock during the 10 trading days prior to
the date of the conversion.

Item 3.02.  Unregistered Sales of Equity Securities.

     In connection with the issuance of the note referenced in Item 2.03 of this
report the Company relied upon the exemption  provided by Section 4(a)(2) of the
Securities Act of 1933. The holder of the note was a sophisticated  investor and
was provided full information  regarding the Company's  business and operations.
There was no general  solicitation  in connection with the issuance of the note.
No commission was paid to any person in connection with issuance of the note.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                      UNITED CANNABIS CORPORATION

Dated:  August 18, 2016              By:  /s/ Chad Ruby
                                          ------------------------------------
                                          Chad Ruby
                                          Chief Operating Officer